Welcome to NovaPharm Therapeutics LLC
NovaPharm Therapeutics (NPT) is an early stage biopharmaceutical company developing new therapeutic options in the treatment of undermanaged, underserved and unmet medical conditions. 

We utilizes a lean development model that enables agility and flexibility at all stages of development. The NovaPharm model establishes early proof-of-concept (POC), reduces key risk factors and adds value to early/mid stage therapies. 

NovaPharm initiated development of NPT101, a novel treatment for Complex Regional Pain Syndrome (CRPS) a devastating condition for which there are no approved treatments. We have recently partnered this compound with a leading pharmaceutical company.

We are actively expanding our development pipeline with a relentless focus on conditions and diseases for which patients have limited options. We are committed to expanding our model and product pipeline to successfully develop new high value therapeutic treatments.

Website Builder